XML 39 R68.htm IDEA: XBRL DOCUMENT v3.20.1
Condensed Consolidating Financial Statements of Aramark and Subsidiaries - Statements of Income And Comprehensive Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Mar. 27, 2020
Mar. 29, 2019
Mar. 27, 2020
Mar. 29, 2019
Condensed Financial Statements, Captions [Line Items]        
Revenue $ 3,731,559 $ 3,999,987 $ 7,985,156 $ 8,265,336
Cost of services provided 3,407,589 3,639,959 7,175,702 7,434,404
Costs and Expenses:        
Depreciation and amortization 147,975 147,908 295,911 298,629
Selling and general corporate expenses 75,071 88,285 158,326 192,415
Goodwill impairment 198,600 0 198,600 0
Gain on sale of Healthcare Technologies 0 1,000 0 (156,309)
Interest and other financing costs, net 99,822 84,178 179,407 167,155
Expense allocations 0 0 0 0
Operating Expense Including Interest And Other Financing Costs 3,929,057 3,961,330 8,007,946 7,936,294
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (197,498) 38,657 (22,790) 329,042
Income tax expense (benefit) 4,523 9,347 33,348 49,054
Equity in Net Income of Subsidiaries 0 0 0 0
Net (loss) income (202,021) 29,310 (56,138) 279,988
Less: Net income (loss) attributable to noncontrolling interest 239 (43) 361 (49)
Net (loss) income attributable to Aramark stockholders (202,260) 29,353 (56,499) 280,037
Other comprehensive loss, net of tax (108,245) (8,655) (87,045) (50,428)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total (310,505) 20,698 (143,544) 229,609
Operating Expenses, Total 3,829,235 3,877,152 7,828,539 7,769,139
Operating Income (97,676) 122,835 156,617 496,197
Eliminations        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Goodwill impairment 0   0  
Gain on sale of Healthcare Technologies   0   0
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Operating Expense Including Interest And Other Financing Costs 0 0 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 0 0 0 0
Income tax expense (benefit) 0 0 0 0
Equity in Net Income of Subsidiaries 202,260 (29,353) 56,499 (280,037)
Net (loss) income 202,260 (29,353) 56,499 (280,037)
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net (loss) income attributable to Aramark stockholders 202,260 (29,353) 56,499 (280,037)
Other comprehensive loss, net of tax 129,736 22,964 83,688 95,266
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total 331,996 (6,389) 140,187 (184,771)
Aramark (Parent) | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 0 0 0 0
Cost of services provided 0 0 0 0
Costs and Expenses:        
Depreciation and amortization 0 0 0 0
Selling and general corporate expenses 0 0 0 0
Goodwill impairment 0   0  
Gain on sale of Healthcare Technologies   0   0
Interest and other financing costs, net 0 0 0 0
Expense allocations 0 0 0 0
Operating Expense Including Interest And Other Financing Costs 0 0 0 0
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 0 0 0 0
Income tax expense (benefit) 0 0 0 0
Equity in Net Income of Subsidiaries (202,260) 29,353 (56,499) 280,037
Net (loss) income (202,260) 29,353 (56,499) 280,037
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net (loss) income attributable to Aramark stockholders (202,260) 29,353 (56,499) 280,037
Other comprehensive loss, net of tax (108,245) (8,655) (87,045) (50,428)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total (310,505) 20,698 (143,544) 229,609
Issuers | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 242,524 260,057 510,959 528,579
Cost of services provided 216,008 234,485 462,316 481,094
Costs and Expenses:        
Depreciation and amortization 4,413 3,817 16,357 8,289
Selling and general corporate expenses 20,374 35,870 50,553 91,612
Goodwill impairment 0   0  
Gain on sale of Healthcare Technologies   0   0
Interest and other financing costs, net 93,396 78,353 168,165 156,912
Expense allocations (85,395) 85,651 (154,994) (144,938)
Operating Expense Including Interest And Other Financing Costs 248,796 438,176 542,397 592,969
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (6,272) (178,119) (31,438) (64,390)
Income tax expense (benefit) 4,277 (35,757) (3,075) (27,017)
Equity in Net Income of Subsidiaries 0 0 0 0
Net (loss) income (10,549) (142,362) (28,363) (37,373)
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net (loss) income attributable to Aramark stockholders (10,549) (142,362) (28,363) (37,373)
Other comprehensive loss, net of tax (67,199) (17,074) (59,181) (44,425)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total (77,748) (159,436) (87,544) (81,798)
Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 2,482,563 2,629,407 5,322,619 5,478,334
Cost of services provided 2,219,994 2,375,337 4,693,171 4,839,939
Costs and Expenses:        
Depreciation and amortization 117,667 118,261 226,904 239,243
Selling and general corporate expenses 46,783 45,374 93,023 86,926
Goodwill impairment 0   0  
Gain on sale of Healthcare Technologies   1,000   (156,309)
Interest and other financing costs, net 661 1,036 1,306 2,007
Expense allocations 82,327 (89,505) 147,705 136,296
Operating Expense Including Interest And Other Financing Costs 2,467,432 2,451,503 5,162,109 5,148,102
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 15,131 177,904 160,510 330,232
Income tax expense (benefit) (11,040) 35,298 11,169 60,298
Equity in Net Income of Subsidiaries 0 0 0 0
Net (loss) income 26,171 142,606 149,341 269,934
Less: Net income (loss) attributable to noncontrolling interest 239 (43) 361 (49)
Net (loss) income attributable to Aramark stockholders 25,932 142,649 148,980 269,983
Other comprehensive loss, net of tax (2,055) 0 (569) 0
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total 23,877 142,649 148,411 269,983
Non Guarantors | Reportable Legal Entities        
Condensed Financial Statements, Captions [Line Items]        
Revenue 1,006,472 1,110,523 2,151,578 2,258,423
Cost of services provided 971,587 1,030,137 2,020,215 2,113,371
Costs and Expenses:        
Depreciation and amortization 25,895 25,830 52,650 51,097
Selling and general corporate expenses 7,914 7,041 14,750 13,877
Goodwill impairment 198,600   198,600  
Gain on sale of Healthcare Technologies   0   0
Interest and other financing costs, net 5,765 4,789 9,936 8,236
Expense allocations 3,068 3,854 7,289 8,642
Operating Expense Including Interest And Other Financing Costs 1,212,829 1,071,651 2,303,440 2,195,223
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest (206,357) 38,872 (151,862) 63,200
Income tax expense (benefit) 11,286 9,806 25,254 15,773
Equity in Net Income of Subsidiaries 0 0 0 0
Net (loss) income (217,643) 29,066 (177,116) 47,427
Less: Net income (loss) attributable to noncontrolling interest 0 0 0 0
Net (loss) income attributable to Aramark stockholders (217,643) 29,066 (177,116) 47,427
Other comprehensive loss, net of tax (60,482) (5,890) (23,938) (50,841)
Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total $ (278,125) $ 23,176 $ (201,054) $ (3,414)